{"raw_mentions": "Here are the extracted sentences/rows that meet the criteria:\n\n\nThe activity of inhibiting PAI-1 production of the compound of the present invention was expressed in terms of the IC50 value and shown in Table 2.\nTABLE 2PAI-1 production-inhibitingCompound No.activity, IC50(\u03bcM)114.1216.835.848.4124.01623.2\nTo C57BL/6 mice (6-week-old, female), bleomycin hydrochloride (Bleo: NIPPON KAYAKU CO., LTD) (6 mg/kg, 25 \u03bcl/animal) was injected into the bronchus together with 500 \u03bcl of compressed air, 0.3 mg/kg of the test substance was suspended in 0.5% carboxymethyl cellulose sodium, and orally administered once daily, 10 \u03bcM TGF-\u03b2 was added thereto and incubated for 24 hours."}
{"final_json": [{"molecule_name": "compound of the present invention", "protein_target_name": "PAI-1", "binding_metric": "IC50", "value": "4.12, 16.83, 5.84, 8.41, 24.01, 623.2", "unit": "\u03bcM"}, {"molecule_name": "bleomycin hydrochloride", "protein_target_name": null, "binding_metric": null, "value": "6", "unit": "mg/kg"}, {"molecule_name": "test substance", "protein_target_name": null, "binding_metric": null, "value": "0.3", "unit": "mg/kg"}, {"molecule_name": "TGF-\u03b2", "protein_target_name": null, "binding_metric": null, "value": "10", "unit": "\u03bcM"}]}
